TwitterFacebookLinkedIn

Preinvasive Disease

The IGCS Preinvasive Certificate Program provides a framework for basic training in preinvasive disease of the female lower genital tract. It is a learning opportunity originating from the needs of the trainees enrolled in the IGCS Global Curriculum and Mentorship Program but it’s also a great educational tool to enhance clinical knowledge and skills in preinvasive cervical disease management for all health care providers in any setting

Aims and Objectives

  • To provide an important educational tool that will help train clinicians so that we can meet the goals and objectives of the WHO Global Strategy to eliminate cervical cancer
  • To build and enhance the knowledge and skills of medical providers all over the world on HPV, HPV vaccination, cervical screening methods and strategies including the diagnosis and treatment of preinvasive cervical disease
  • To equip IGCS members with evidence-based knowledge for preventing, screening, diagnosing, and treating patients with preinvasive cervical diseases regardless of the setting they work in

Target Audience
Physicians including gynecologic oncologists, gynecologists, family medicine doctors, general doctors, nurse practitioners, physician assistants, nurses, and other healthcare providers who are already involved or keen to be involved in the prevention and treatment of cervical cancer and other HPV related diseases.

Phases
The program will be delivered in three phases:

  • Phase 1: Basic Theory (self-guided education)
  • Phase 2: Advanced Theory (self-guided education)
  • Phase 3: Practical/Competence Assessment (hands-on training)

The first opportunity for hands-on training will be provided at the IGCS Annual Global Meeting in New York on September 28, 2022. Additional training dates and locations will be announced.

All three phases must be completed before the learner will receive a certificate of completion for technical competency in colposcopy and treatment of preinvasive cervical disease. Learners who complete only phases 1 and 2 will receive a certificate of knowledge that does not certify technical competency.

View additional details and requirements about the preinvasive disease curriculum.

Those who enroll will receive an email with instructions how to access the course within 24 hours. To optimize your experience, please clear your browsing history and cookies prior to beginning the course. The recommended web browser is Google Chrome.

Leads
Mila Pontremoli Salcedo, MD, PhD
Ida Ismail-Pratt, MBChB, MRCOG

Contributors
Ellen S. Baker, MD, MPH
James Bentley, MBChB, FRCSC
Julia Brotherton, PhD
Maggie E. Cruickshank, MD
Gustavo Ruvino De Azevedo Focchi, MD, PhD
Suzanne Garland, AO, MBBS, MD, FRCPA, FRANZCOG Ad Eundem, FAChSHM, FASM, FACOG Hons

Jose Jeronimo, MD
Rachel Masch, MD, MPH
EJ Mayeaux, Jr., MD, DABFP, DABPM-CI, FAAFP
Jane R. Montealegre, PhD, MSPH
Joseph Ng, MD, FACOG, FAMS
Katina Robison, MD
Kathleen Schmeler, MD
Erich Madison Sturgis, MD, MPH
Melissa Lopez Varon M.Sc.
Alan G. Waxman, MD, MPH